Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
Open Access
- 4 March 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 806869
Abstract
Breast cancer ranks as the leading cause of death in lethal malignancies among women worldwide, with a sharp increase of incidence since 2008. Triple negative breast cancer (TNBC) gives rise to the largest proportion in breast cancer-related deaths because of its aggressive growth and rapid metastasis. Hence, searching for promising targets and innovative approaches is indispensable for the TNBC treatment. Maackiain (MA), a natural compound with multiple biological activities, could be isolated from different Chinese herbs, such as Spatholobus suberectus and Sophora flavescens. It was the first time to report the anti-cancer effect of MA in TNBC. MA could suppress TNBC cell proliferation, foci formation, migration, and invasion. MA also exerted a significant inhibitory effect on tumor growth of TNBC. Furthermore, MA could induce apoptosis with an increase of GADD45α and a decrease of miR-374a. In contrast, overexpressing miR-374a would result in at least partly affecting the proapoptotic effect of MA and suppressing GADD45α stimulated by MA. These results reveal the anti-TNBC effect of MA in vitro and in vivo, providing evidence for its potential as a drug candidate utilized in TNBC therapy.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- China Association for Science and Technology
This publication has 41 references indexed in Scilit:
- dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancersNucleic Acids Research, 2016
- Maackiain is a novel antiallergic compound that suppresses transcriptional upregulation of the histamine H1 receptor and interleukin‐4 genesPharmacology Research & Perspectives, 2015
- Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapyJournal of Experimental & Clinical Cancer Research, 2013
- Gadd45a Suppresses Tumor Angiogenesis via Inhibition of the mTOR/STAT3 Protein Pathway*Journal of Biological Chemistry, 2013
- Bioactivity-Guided Identification and Cell Signaling Technology to Delineate the Lactate Dehydrogenase A Inhibition Effects of Spatholobus suberectus on Breast CancerPLOS ONE, 2013
- MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasisJournal of Clinical Investigation, 2013
- MicroRNAs in Stress Signaling and Human DiseaseCell, 2012
- Gadd45a Is an RNA Binding Protein and Is Localized in Nuclear SpecklesPLOS ONE, 2011
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Induction of apoptosis by maackiain and trifolirhizin (maackiain glycoside) isolated from sanzukon (Sophora Subprostrate Chen et T. Chen) in human promyelotic leukemia HL-60 cellsOncology Reports, 2004